Literature DB >> 6789587

Hemoglobin Bart's in Northern Algeria.

T Henni, D Bachir, P Tabone, P Jurdic, J Godet, P Colonna.   

Abstract

The hemoglobin patterns of 293 cord bloods from Northern Algeria were examined by electrophoresis on cellulose-acetate strips. A fast-moving component, identified as Hb Bart's, was found in about 10% of the cases. The levels of Hb Bart's ranged from 0.1 to 10% of the total hemoglobin. There was a significant correlation between the Hb Bart's levels and the decrease in MCV. The relative rates of globin chain synthesis measured by 3H-leucine incorporation was estimated in 15 cord bloods. It was found imbalanced in the 5 cord bloods which contained more than 0.5% Hb Bart's. These findings suggest that elevated Hb Bart's levels in the Algerian population are due to the presence of alpha-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789587     DOI: 10.1159/000207187

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Alpha-thalassemia haplotypes in the Algerian population.

Authors:  T Henni; F Morlé; B Lopez; P Colonna; J Godet
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

2.  Alpha thalassemia among sickle cell anaemia patients in Kampala, Uganda.

Authors:  Irene Lubega; Christopher M Ndugwa; Edison A Mworozi; James K Tumwine
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

3.  alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

Authors:  H Siala; F Ouali; T Messaoud; A Bibi; S Fattoum
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 4.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.